
Brookfield Corporation is rated a Buy ahead of its Q3 earnings as the company is expected to ramp up monetization of legacy carried interest, generating significant cash flow. The value of its stake in BAM covers about 74% of its share price, with additional value from carry, insurance, and real estate assets. Key near-term drivers include accelerating carry realization, increased share buybacks, and growth in insurance and asset management earnings. While risks include market discounting and BAM's cyclical nature, the overall risk/reward profile is favorable with multiple positive catalysts expected soon.
Brookfield Corporation's shares are trading at USD 39.14 on Pluang as of Oct 31, 2026 00:12 WIB, down 0.91% for the day. This price sits closer to the 52-week low of USD 35.95 than the high of USD 49.17, indicating the stock is currently valued below its peak range despite the positive outlook and expected catalysts mentioned in the news. The dividend yield stands at 0.71%, reflecting a modest income component relative to its market cap of $88.11 billion.